DBN1 and prostate carcinoma: To investigate the expression of drebrin and pS142-drebrin in a larger cohort of benign and malignant prostate tissue samples we analysed a tissue microarray of human prostate sections from patients who had undergone radical prostatectomy as primary treatment for prostate cancer.